All News

The average Affordable Care Act (ACA) Marketplace deductible experienced the steepest increase in history—grow…

With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknow…

As next-generation GLP-1 contenders rise, key readouts are on the way from Pfizer, Viking Therapeutics and Eli…

Regeneron Pharmaceuticals’ LAG-3 inhibitor called fianlimab has flunked a late-stage skin cancer trial, markin…

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be head…

Aardvark Therapeutics is planning to unblind data from its phase 3 Prader-Willi syndrome program after the FDA…

One of the key products underpinning AstraZeneca’s goal of hitting $80 billion in revenue by 2030 has been app…

The FDA has approved Daiichi Sankyo and AstraZeneca’s Enhertu for two new indications in HER2-positive early b…

A number of Americans who are in the Congo are believed to have had exposure to suspected cases in the country…

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator is heading …

Takeda's multiyear slim-down is expected to hit about 4,500 roles during the 2026 fiscal year, resulting in ab…

The U.S. Supreme Court has issued an emergency order, temporarily blocking a federal appeals court ruling in L…

A phase 2 trial of Biogen and Ionis Pharmaceuticals’ tau-targeting candidate missed its primary endpoint. But …

The leader of the FDA's drug division, Tracy Beth Høeg, is expected to depart, as part of a broad shakeup at t…

Biopharma's deals landscape could hardly be better, as large companies take a multi-pronged approach to withst…

Amgen is expanding its claims data requirements for pharmacies dispensing its drugs under the 340B federal dru…

The ruling maintains access to the drug while litigation continues. Mifepristone can still be prescribed at ph…

CMS is taking a new approach to fraud that will rely more heavily on options to pause or withhold significant …

A new Ebola outbreak has been confirmed in Congo’s remote Ituri province, with 246 suspected cases and 65 deat…

A record Sun Pharma acquisition signals global ambitions. But infrastructure, capital and policy gaps could st…

During ECO 2026, a study was presented analysing the use of tirzepatide, a dual GIP and GLP-1 agonist, in trea…